Press "Enter" to skip to content

ICICI Direct Issues Buy Recommendation for PPL Pharma

By bigbreakingwire on 30/09/2024

ICICI Direct Issues Buy Recommendation for PPL Pharma

ICICI Direct has set a target price of Rs 280 for PPL Pharma, up from the current price of Rs 226.31, indicating a potential upside of 23.72%.

<img decoding="async" alt="bigbreakingwire" src="https://secure.gravatar.com/avatar/062544ed21dde0fd778a0543505667ffdb9fa0c337d16715f48c98dbd85d38b8?s=100&d=mm&r=g" srcset="https://secure.gravatar.com/avatar/062544ed21dde0fd778a0543505667ffdb9fa0c337d16715f48c98dbd85d38b8?s=200&d=mm&r=g 2x" class="avatar avatar-100 photo" height="100" width="100" itemprop="image" title="ICICI Direct Issues Buy Recommendation for PPL Pharma">

bigbreakingwire

Bringing you the latest updates on finance, economies, stocks, bonds, and more. Stay informed with timely insights.

bigbreakingwire.in

Published in Brokerage Reports

bigbreakingwire

Bringing you the latest updates on finance, economies, stocks, bonds, and more. Stay informed with timely insights.

More from Brokerage ReportsMore posts in Brokerage Reports »

Be First to Comment

Leave a Reply Cancel reply